Sage Rhino Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $864K | Buy |
2,387
+19
| +0.8% | +$6.5K | 0.14% | 112 |
|
|
2026
Q1 | $833K | Sell |
2,368
-1
| -0% | -$356 | 0.16% | 107 |
|
|
2025
Q4 | $775K | Sell |
2,369
-29
| -1% | -$9.2K | 0.15% | 115 |
|
|
2025
Q3 | $677K | Buy |
2,398
+1
| +0% | +$290 | 0.13% | 119 |
|
|
2025
Q2 | $669K | Sell |
2,397
-6
| -0.2% | -$1.7K | 0.14% | 113 |
|
|
2025
Q1 | $749K | Sell |
2,403
-20
| -0.8% | -$5.91K | 0.17% | 101 |
|
|
2024
Q4 | $632K | Sell |
2,423
-34
| -1% | -$10.1K | 0.14% | 113 |
|
|
2024
Q3 | $792K | Buy |
2,457
+4
| +0.2% | +$1.31K | 0.18% | 105 |
|
|
2024
Q2 | $766K | Sell |
2,453
-51
| -2% | -$15K | 0.18% | 103 |
|
|
2024
Q1 | $712K | Buy |
2,504
+34
| +1% | +$9.95K | 0.17% | 106 |
|
|
2023
Q4 | $711K | Sell |
2,470
-3
| -0.1% | -$817 | 0.18% | 103 |
|
|
2023
Q3 | $665K | Buy |
2,473
+4
| +0.2% | +$998 | 0.19% | 102 |
|
|
2023
Q2 | $548K | Sell |
2,469
-79
| -3% | -$18.3K | 0.15% | 110 |
|
|
2023
Q1 | $616K | Sell |
2,548
-1,445
| -36% | -$355K | 0.18% | 103 |
|
|
2022
Q4 | $1.05M | Buy |
3,993
+1,493
| +60% | +$400K | 0.33% | 63 |
|
|
2022
Q3 | $564K | Sell |
2,500
-31
| -1% | -$7.51K | 0.23% | 82 |
|
|
2022
Q2 | $616K | Sell |
2,531
-6
| -0.2% | -$1.47K | 0.24% | 80 |
|
|
2022
Q1 | $613K | Buy |
2,537
+8
| +0.3% | +$1.84K | 0.19% | 100 |
|
|
2021
Q4 | $569K | Buy |
2,529
+41
| +2% | +$8.65K | 0.16% | 113 |
|
|
2021
Q3 | $529K | Buy |
2,488
+23
| +0.9% | +$5.29K | 0.16% | 103 |
|
|
2021
Q2 | $601K | Buy |
2,465
+16
| +0.7% | +$3.94K | 0.18% | 94 |
|
|
2021
Q1 | $609K | Buy |
2,449
+127
| +5% | +$30.3K | 0.2% | 86 |
|
|
2020
Q4 | $534K | Hold |
2,322
| – | – | 0.21% | 85 |
|
|
2020
Q3 | $590K | Sell |
2,322
-2
| -0.1% | -$495 | 0.29% | 70 |
|
|
2020
Q2 | $548K | Buy |
2,324
+97
| +4% | +$22.1K | 0.29% | 74 |
|
|
2020
Q1 | $451K | Sell |
2,227
-23
| -1% | -$5.02K | 0.32% | 68 |
|
|
2019
Q4 | $536K | Sell |
2,250
-37
| -2% | -$8.16K | 0.31% | 72 |
|
|
2019
Q3 | $443K | Buy |
2,287
+76
| +3% | +$14.6K | 0.28% | 73 |
|
|
2019
Q2 | $407K | Sell |
2,211
-119
| -5% | -$21.3K | 0.26% | 80 |
|
|
2019
Q1 | $443K | Buy |
+2,330
| New | +$445K | 0.29% | 71 |
|
Other funds holding AMGN
Sage Rhino Capital's AMGN Position: Q2 2026 in Review
Sage Rhino Capital increased its Amgen (AMGN) stake by 0.8% in Q2 2026, buying an estimated $6.5K and bringing the position to 2,387 shares worth $864K. The position accounts for 0.14% of the portfolio, ranked #112.
Sage Rhino Capital first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.05M in Q4 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sage Rhino Capital held 2,387 shares of Amgen worth $864K as of Q2 2026.
- Sage Rhino Capital bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
- Amgen made up 0.14% of Sage Rhino Capital's portfolio in Q2 2026, its #112 holding.
- Sage Rhino Capital first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- Sage Rhino Capital's Amgen position peaked at $1.05M in Q4 2022.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.